Galectin-3 targeting in thyroid orthotopic tumors opens new ways to characterize thyroid cancer

F De Rose, M Braeuer… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Preoperative characterization of thyroid nodules is challenging since thyroid scintigraphy
fails to distinguish between benign and malignant lesions. Galectin-3 (gal-3) is expressed in …

Development of a chimeric antigen-binding fragment directed against human galectin-3 and validation as an immuno-positron emission tomography tracer for the …

E Peplau, F De Rose, S Reder, M Mittelhaeuser… - Thyroid, 2020 - liebertpub.com
Background: The lack of facile methods for the specific characterization of malignant thyroid
nodules makes the diagnosis of thyroid cancer (TC) challenging. Due to its restricted …

[HTML][HTML] Thyroid Cancer Imaging In Vivo by Targeting the Anti-Apoptotic Molecule Galectin-3

A Bartolazzi, C D'Alessandria, MG Parisella… - PLoS …, 2008 - journals.plos.org
Background The prevalence of thyroid nodules increases with age, average 4–7% for the
USA adult population, but it is much higher (19–67%) when sub-clinical nodules are …

[HTML][HTML] Galectin-3: the impact on the clinical management of patients with thyroid nodules and future perspectives

A Bartolazzi, S Sciacchitano… - International journal of …, 2018 - mdpi.com
Galectins (S-type lectins) are an evolutionarily-conserved family of lectin molecules, which
can be expressed intracellularly and in the extracellular matrix, as well. Galectins bind β …

[HTML][HTML] Effective rational humanization of a PASylated anti-galectin-3 Fab for the sensitive PET imaging of thyroid cancer in vivo

E Peplau, F De Rose, A Eichinger, S Reder… - Scientific reports, 2021 - nature.com
The lack of a non-invasive test for malignant thyroid nodules makes the diagnosis of thyroid
cancer (TC) challenging. Human galectin-3 (hGal3) has emerged as a promising target for …

Beyond immunohistochemistry and immunocytochemistry: a current perspective on galectin-3 and thyroid cancer

J Li, E Vasilyeva, SM Wiseman - Expert Review of Anticancer …, 2019 - Taylor & Francis
Introduction: Thyroid nodules are very common in the general population, most are benign,
and do not require any intervention. However, often a challenge exists in discriminating …

[HTML][HTML] Diagnostic utility of galectin-3 in thyroid cancer

CG Chiu, SS Strugnell, OL Griffith, SJM Jones… - The American journal of …, 2010 - Elsevier
Galectin-3 (Gal-3), which has received significant recent attention for its utility as a
diagnostic marker for thyroid cancer, represents the most well-studied molecular candidate …

Noninvasive In Vivo Imaging and Biologic Characterization of Thyroid Tumors by ImmunoPET Targeting of Galectin-3

C D'Alessandria, S Braesch-Andersen, K Bejo, S Reder… - Cancer research, 2016 - AACR
The high prevalence of thyroid nodules in the adult population and the relatively low
incidence of thyroid cancer make the preoperative identification of malignant lesions …

[HTML][HTML] Galectin-1 is a diagnostic marker involved in thyroid cancer progression

V Arcolia, F Journe, A Wattier… - International …, 2017 - spandidos-publications.com
Fine-needle aspiration (FNA) is the most commonly used pre-operative technique for
diagnosis of malignant thyroid tumor. However, many benign lesions, with indeterminate …

Galectin‐3 expression in thyroid fine needle cytology (t‐FNAC) uncertain cases: Validation of molecular markers and technology innovation

F Papale, G Cafiero, A Grimaldi… - Journal of cellular …, 2013 - Wiley Online Library
Thyroid cancer is not very common, accounting for 1–2% of all cancers, with a population
incidence of about 0.004%. Currently, the ability to discriminate between follicular adenoma …